Integrated BioTherapeutics integratedbiotherapeutics.com


Integrated BioTherapeutics is a biotechnology company focusing on the discovery of novel vaccines and therapies for emerging infectious diseases with a pipeline that includes promising product candidates for bacterial and viral infections, including pan-filovirus immunotherapeutics and vaccines, vaccines for Staphylococcal infections, and a variety of other product candidates for emerging viruses.

Integrated BioTherapeutics is a biotechnology company focusing on the discovery of novel vaccines and therapies for emerging infectious diseases with a pipeline that includes promising product candidates for bacterial and viral infections, including ...Show all

Company (Alive / Active)

All investors data 1 Investors

Phone: 877-411-2041

Fax:

4 Research Court
Suite 300
 Rockville, 20850
 Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Integrated BioTherapeutics $6.6M Aug 2, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Integrated BioTherapeutics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof Jun 18, 2014 Nov 14, 2017 Patent
Immunogenic composition comprising alpha-hemolysin oligopeptides Feb 06, 2012 Aug 18, 2015 Patent
Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof Nov 13, 2017 Application
Equine immunoglobulin compositions and uses for treating filovirus-mediated diseases Jan 28, 2016 Application
Immunogenic composition comprising engineered alpha-hemolysin oligopeptides Jan 06, 2016 Application
See all 10 patents